Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase P1 (GSTP1) is a member of the glutathione S-transferase (GST) superfamily, specifically belonging to the pi class. GSTs are phase II detoxification enzymes that catalyze the conjugation of reduced glutathione (GSH) to a wide range of hydrophobic and electrophilic compounds, facilitating their detoxification and excretion. GSTP1 is encoded by the polymorphic *GSTP1* gene. It plays a critical role in cellular defense against toxins and oxidative stress and is implicated in drug resistance and cancer.
Catalyzes conjugation of glutathione to electrophilic compounds, detoxifying them. Inhibits JNK, preventing apoptosis. Silencing of GSTP1 expression.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase P1 (GSTP1).